Argent Biopharma - Edison Group

Overview
Price performance
Financials
Research
Thematics

Argent Biopharma is an Australia-headquartered specialist medical cannabis biopharma company, which has most of its operations based in Europe.

Latest Insights

View More

Healthcare |
Update

04.11.19

MGC Pharmaceuticals — Rapid prescription growth in Australia and the UK

Healthcare |
Update

10.07.19

MGC Pharmaceuticals — Initial CannEpil purchase orders received

Healthcare |
Update

01.03.19

MGC Pharmaceuticals — MGC Derma sale completed

Healthcare |
Initiation

22.10.18

MGC Pharmaceuticals — Cannabis-based medicines and cosmetics

Sector

Healthcare

Equity Analyst

Nidhi Singh

Analyst

Jyoti Prakash

Analyst, Healthcare

Associate analyst

Soo Romanoff

Managing Director - Head of Content, Healthcare

Key Management

Igor Bluvstein

CFO
Roby Zomer

Managing Director and Co-CEO
Yifat Steuer

COO

Share Price Performance

Price Performance
%	1M	3M	12M
Actual	-21.5	-28.7	-93.8
Relative	-21.3	-28.3	-94.3
52 week high/low	6/0.295

Financials

Since beginning in earnest in August this year, 1,000 prescriptions for MGC’s phytocannabinoid products (CannEpil and MXP100) have been issued in Australia and the UK. Double the number of prescriptions were issued in October compared to September. Cash receipts for the quarter ending 30 September were A$413,000, with additional revenue of more than A$400,000 from recent sales expected to be received following the end of the quarter.

Y/E Jun	Revenue (£m)	EBITDA (£m)	PBT (£m)	EPS (p)	P/E (x)	P/CF (x)
2008A	0.1	(1.2)	(1.4)	(11.5)	N/A	N/A
2009A	0.1	(0.4)	(0.7)	(2.4)	N/A	N/A
2010E	0.5	(0.5)	(0.6)	(1.1)	N/A	N/A
2011E	N/A	N/A	N/A	N/A	N/A	N/A

Research

thematic

Healthcare

26.01.23

Machine learning in drug development

thematic

Healthcare

06.01.23

Outlook for 2023: Biotechs remain central to novel drug development

Cancer cells

thematic

Healthcare

04.01.23

Oncology ABCs (part four): Blood cancers (AML) – notable innovations

cell DNA double helix

thematic

Healthcare

20.12.22

Cell and gene therapies

thematic

Healthcare

28.11.22

Drug delivery platforms

thematic

Healthcare

07.11.22

Oncology ABCs (part three) – thinking outside the box in women’s cancer

thematic

Healthcare

01.11.22

Neuroscience comeback

thematic

Consumer

05.10.22

IPO apocalypse

thematic

Healthcare

03.10.22

Oncology ABCs (part two) – vaccines: niche no longer

thematic

TMT

10.08.22

ESG, moving beyond the box tick

thematic

Healthcare

01.07.22

Oncology ABCs (part one) – a small-cap biopharma prospectus series

thematic

Healthcare

26.04.22

Cannabinoid manufacturing – Innovative approaches to the production of cannabinoids

thematic

Healthcare

10.11.21

Artificial intelligence in drug discovery

thematic

Healthcare

27.07.21

Biosynthesis – Taking the cannabinoid market to new heights

thematic

Healthcare

01.02.21

Confidence renewed as new COVID-19 vaccines demonstrate protection against emergent strains and efficacy with a single-dose regimen

thematic

Healthcare

30.10.19

Edison Exhibits- antibiotic development

thematic

Healthcare

17.07.19

The next wave in AMD

thematic

Healthcare

18.06.19

The A-B-T of biosimilars- Explaining contemporary life science issues

thematic

Healthcare

10.06.19

Cannabinoid Therapies- The coming retail wave

thematic

Healthcare

22.05.19

Cannabinoid Therapies- Therapeutics turning a corner

thematic

Healthcare

08.04.19

Trial outcomes and value – Explaining contemporary clinical trial issues

thematic

Healthcare

04.03.19

Drug pricing – Market access and reimbursement

thematic

Healthcare

29.01.19

The diagnostics sector

thematic

Healthcare

21.06.17

ASCO 2017

thematic

Consumer

11.11.14

Deutsche Börse Eigenkapitalforum 2014 Research Guide

thematic

Healthcare

05.03.14

Edison healthcare quarterly: A boost for allergy immunotherapy

thematic

Energy & Resources

04.03.14

ASX Spotlight Conference – London, 6 March 2014

thematic

Energy & Resources

01.03.13

ASX Small to Mid Caps Conference – London, 7 March 2013

thematic

Healthcare

07.12.12

Edison healthcare quarterly: Boom times for US biotech

thematic

Healthcare

30.08.12

Edison healthcare quarterly: Crisis? What crisis?

thematic

Healthcare

28.05.12

Edison healthcare quarterly: How to please some of the people some of the time